Health and Wellness Informatics News
No one can deny the increase in telehealth uptake. It is taking place among people existing with at-risk and HIV individuals in Asia-Pacific.
Concerns are related to data privacy and insufficient in-person support. People are avoiding onboarding with online healthcare services. Gilead Sciences, a global biopharmaceutical company, has conducted this survey.
The survey collected responses from about 1500 individuals across 9 APAC markets. It also includes Vietnam, Thailand, Taiwan, South Korea, Singapore, Philippines, Malaysia, India, and Hong Kong.
As per a survey in 2020, more than half of PHLIVs in APAC cannot access telehealth services.
As per a current survey, over half of the at-risk individuals and PLHIV has now increased telehealth uptake. It happened last year. The result also came from Malaysia, Vietnam, and the Philippines.
The result has improved because of the rising use of telehealth services. People are also choosing telehealth for enhanced access, flexibility, and convenience.
Virtual healthcare services adaptation is rising. Telehealth operators can tailor the services to the needs of the clients. The use of telehealth is also very high, even after the covid-19 crisis. It is essential to make sure that the equity of access is intact.
Community-based organizations and healthcare providers need to use innovation. It is indispensable in care, like offering e-prescriptions. The healthcare systems also need to adapt to the patient’s requirements. Also, it is essential to modernize HIV services.
Also, people are tense about data privacy with the increasing risk of cyber security attacks. The 1st online pharmacy in Kenya, MYDAWA, is all set to start a new telehealth uptake service. The target is to seek access to Pre-Exposure Prophylaxis. It is also a medicine for people at risk of having HIV.
The pandemic has influenced people to stay active in their health. The telehealth services may offer additional support to the existing services. It will also retain PHLIV in care.